Arbutus Biopharma Corp

ABUS | NASDAQ

Price Alert Chart Builder DCF Calculator

$5

-$0.01 (-0.20%)

At close: Sep 21, 2026, 4:00 PM ET

$4.98

-$0.02 (-0.40%)

Pre-market: Sep 22, 2026, 8:47 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-33.5M	-69.92M	-72.85M	-69.46M	-76.25M	-63.75M
Depreciation & Amortization	363K	1.38M	1.4M	1.43M	1.75M	1.98M
Stock-Based Compensation	6.95M	8.99M	9.3M	7.18M	6.42M	6.16M
Other Working Capital	-9.29M	-2.2M	-17.81M	24.48M	517K	-1.13M
Other Non-Cash Items	-3.43M	-2.47M	-5.56M	-3.75M	7.79M	3.73M
Deferred Income Tax	n/a	n/a	n/a	n/a	-8.18M	n/a
Change in Working Capital	-10.02M	-2.83M	-18.23M	29.24M	930K	431K
Operating Cash Flow	-39.64M	-64.85M	-85.94M	-35.36M	-67.53M	-51.44M
Capital Expenditures	n/a	-182K	-1.01M	-512K	-809K	-229K
Cash Acquisitions	n/a	n/a	n/a	n/a	1.81M	-2.5M
Purchase of Investments	12.87M	-141.51M	-80.51M	-130.43M	-82.22M	-85.58M
Sales Maturities Of Investments	155.28M	164.64M	132.27M	56M	70.35M	73.4M
Other Investing Acitivies	-152.56M	n/a	20K	n/a	-1.81M	n/a
Investing Cash Flow	15.58M	22.95M	50.77M	-74.94M	-12.68M	-14.91M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	-12.14M	n/a
Other Financial Acitivies	n/a	7.87M	795K	11.49M	14.71M	449K
Financial Cash Flow	5.72M	52M	30.65M	31.81M	137.24M	86.75M
Net Cash Flow	-18.32M	10.05M	-4.49M	-78.51M	57.03M	20.45M
Free Cash Flow	-39.64M	-65.03M	-86.94M	-35.87M	-68.34M	-51.67M
Adj. Free Cash Flow	-46.59M	-74.02M	-96.25M	-43.05M	-74.77M	-57.83M
Maintenance CapEx	n/a	-182K	-1.01M	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	-512K	-809K	-229K
Owner Earnings	-39.64M	-65.03M	-86.94M	-35.36M	-67.53M	-51.44M